How many institutional investors hold ABBV?

5 tracked institutional investors disclosed a position in ABBV (ABBVIE INC) in their most recent 13F filing.

Who is the largest institutional holder of ABBV?

Ken Griffin, Citadel Advisors, holds the largest disclosed position in ABBV, valued at $1.7B.

What sector is ABBV in?

ABBVIE INC is classified in the Health Care GICS sector, Drug Manufacturers industry.

Where does this ABBV ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

ABBV — ABBVIE INC

Name: ABBVIE INC (ABBV) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Health Care · Drug Manufacturers

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying ABBV?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Net distribution · 3 buying vs 2 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Congressional Activity

1 congressional purchase, 1 sale disclosed in the last 6 months

Why? — Evidence & Confidence ▾

Of 5 tracked investors who changed their ABBV position last quarter, 3 bought and 2 sold (60% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Overheat regime). 1 congressional purchase, 1 sale disclosed in the last 6 months.

Supporting evidence

+3 tracked investors added or increased positions last quarter (Izzy Englander, Ken Griffin, Steve Cohen)
+5 tracked investors reported holding ABBV at their latest filing

Contradicting evidence — always shown

−2 tracked investors reduced or exited last quarter (2 reduced, 0 sold out)
−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About ABBVIE INC (ABBV)

ABBVIE INC (ABBV) appears in the most recent 13F filings of 5 tracked institutional investors. ABBVIE INC is classified in the Health Care sector (Drug Manufacturers industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $1.7B. Across recent filings, tracked investors recorded 6 new positions, 15 increased, 18 reduced, and 2 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ABBV

/100

Mixed Activity

Added / Increased21

Reduced18

Exited2

BearishBullish

Crowded Trade Score™

How many top investors track ABBV

/100

Emerging Interest

5investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

ABBV Ownership Composition

How ABBVIE INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Multi-Strategy / Quant

96% of tracked value

Institutions

tracked investors

Total Reported

$2.4B

combined 13F value

Multi-Strategy / Quant96.2%
Macro3.8%

Multi-Strategy / Quant(3)

96.2%

Macro(2)

3.8%

Tracked investors currently reporting ABBV

Investor	Firm	Shares	Market value	% of portfolio	As of
Ken Griffin	Citadel Advisors	6.6M	$1.7B	0.19%	Jun 30, 2026
Izzy Englander	Millennium Management	2.3M	$569.6M	0.21%	Jun 30, 2026
Ray Dalio	Bridgewater Associates	11.8K	$3M	0.01%	Jun 30, 2026
Steve Cohen	Point72 Asset Management	388.3K	$97.7M	0.11%	Jun 30, 2026
Paul Tudor Jones	Tudor Investment Corp	347.9K	$87.5M	0.12%	Jun 30, 2026

Ken GriffinJun 30, 2026
Citadel Advisors
Shares
6.6M
Value
$1.7B
% Portfolio
0.19%
Izzy EnglanderJun 30, 2026
Millennium Management
Shares
2.3M
Value
$569.6M
% Portfolio
0.21%
Ray DalioJun 30, 2026
Bridgewater Associates
Shares
11.8K
Value
$3M
% Portfolio
0.01%
Steve CohenJun 30, 2026
Point72 Asset Management
Shares
388.3K
Value
$97.7M
% Portfolio
0.11%
Paul Tudor JonesJun 30, 2026
Tudor Investment Corp
Shares
347.9K
Value
$87.5M
% Portfolio
0.12%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Izzy Englander	Reduced	-25.31%	$408M	Nov 14, 2024
Izzy Englander	Reduced	-43.69%	$206.7M	Feb 14, 2025
Izzy Englander	Increased	97.32%	$480.9M	May 15, 2025
Izzy Englander	Increased	42.48%	$607M	Aug 14, 2025
Izzy Englander	Reduced	-67.16%	$237.7M	Feb 17, 2026
Izzy Englander	Increased	61.26%	$364.8M	May 15, 2026
Izzy Englander	Increased	34.93%	$569.6M	Aug 14, 2026
Ken Griffin	Increased	34.88%	$905M	Nov 14, 2024
Ken Griffin	Increased	67.45%	$1.4B	May 15, 2025
Ken Griffin	Reduced	-1.03%	$1.3B	Aug 14, 2025
Ken Griffin	Sold	-100.00%	$0	Nov 14, 2025
Ken Griffin	Increased	75.56%	$1.7B	Aug 14, 2026
Ray Dalio	Increased	5.37%	$94.1M	Feb 14, 2024
Ray Dalio	Reduced	-25.89%	$81.9M	May 14, 2024
Ray Dalio	Reduced	-35.85%	$49.5M	Aug 14, 2024
Ray Dalio	Reduced	-29.10%	$40.4M	Nov 13, 2024
Ray Dalio	Increased	39.98%	$50.9M	Feb 13, 2025
Ray Dalio	Reduced	-63.35%	$22M	May 14, 2025
Ray Dalio	Increased	470.06%	$111.1M	Aug 13, 2025
Ray Dalio	Reduced	-56.43%	$60.4K	Nov 13, 2025
Ray Dalio	Reduced	-94.55%	$3.2K	Feb 13, 2026
Ray Dalio	Increased	113.68%	$6.6M	May 15, 2026
Ray Dalio	Reduced	-61.22%	$3M	Aug 14, 2026
Steve Cohen	New	—	$18.9M	Jul 21, 2025
Steve Cohen	Reduced	-94.21%	$967.1K	Aug 14, 2025
Steve Cohen	Increased	6799.12%	$83.2M	Nov 14, 2025
Steve Cohen	Reduced	-70.68%	$24.1M	Feb 17, 2026
Steve Cohen	Reduced	-61.95%	$8.7M	May 15, 2026
Steve Cohen	Increased	868.42%	$97.7M	Aug 14, 2026
Paul Tudor Jones	Reduced	-67.68%	$4.6M	Aug 14, 2024
Paul Tudor Jones	Reduced	-26.32%	$3.9M	Nov 14, 2024
Paul Tudor Jones	Increased	18.88%	$4.1M	Feb 14, 2025
Paul Tudor Jones	Sold	-100.00%	$0	May 15, 2025
Paul Tudor Jones	New	—	$94.9M	Aug 14, 2025
Paul Tudor Jones	Reduced	-21.66%	$92.8M	Dec 9, 2025
Paul Tudor Jones	Increased	54.99%	$83.7M	May 15, 2026
Paul Tudor Jones	Reduced	-9.58%	$87.5M	Aug 14, 2026
Ray Dalio	New	—	$85.9M	Nov 13, 2023
Ken Griffin	New	—	$582.8M	Aug 14, 2024
Izzy Englander	New	—	$293.8M	May 15, 2024
Paul Tudor Jones	New	—	$15M	May 15, 2024

Izzy Englander
Reduced
$408M(-25.31%)Nov 14, 2024
Izzy Englander
Reduced
$206.7M(-43.69%)Feb 14, 2025
Izzy Englander
Increased
$480.9M(97.32%)May 15, 2025
Izzy Englander
Increased
$607M(42.48%)Aug 14, 2025
Izzy Englander
Reduced
$237.7M(-67.16%)Feb 17, 2026
Izzy Englander
Increased
$364.8M(61.26%)May 15, 2026
Izzy Englander
Increased
$569.6M(34.93%)Aug 14, 2026
Ken Griffin
Increased
$905M(34.88%)Nov 14, 2024
Ken Griffin
Increased
$1.4B(67.45%)May 15, 2025
Ken Griffin
Reduced
$1.3B(-1.03%)Aug 14, 2025
Ken Griffin
Sold
$0(-100.00%)Nov 14, 2025
Ken Griffin
Increased
$1.7B(75.56%)Aug 14, 2026
Ray Dalio
Increased
$94.1M(5.37%)Feb 14, 2024
Ray Dalio
Reduced
$81.9M(-25.89%)May 14, 2024
Ray Dalio
Reduced
$49.5M(-35.85%)Aug 14, 2024
Ray Dalio
Reduced
$40.4M(-29.10%)Nov 13, 2024
Ray Dalio
Increased
$50.9M(39.98%)Feb 13, 2025
Ray Dalio
Reduced
$22M(-63.35%)May 14, 2025
Ray Dalio
Increased
$111.1M(470.06%)Aug 13, 2025
Ray Dalio
Reduced
$60.4K(-56.43%)Nov 13, 2025
Ray Dalio
Reduced
$3.2K(-94.55%)Feb 13, 2026
Ray Dalio
Increased
$6.6M(113.68%)May 15, 2026
Ray Dalio
Reduced
$3M(-61.22%)Aug 14, 2026
Steve Cohen
New
$18.9MJul 21, 2025
Steve Cohen
Reduced
$967.1K(-94.21%)Aug 14, 2025
Steve Cohen
Increased
$83.2M(6799.12%)Nov 14, 2025
Steve Cohen
Reduced
$24.1M(-70.68%)Feb 17, 2026
Steve Cohen
Reduced
$8.7M(-61.95%)May 15, 2026
Steve Cohen
Increased
$97.7M(868.42%)Aug 14, 2026
Paul Tudor Jones
Reduced
$4.6M(-67.68%)Aug 14, 2024
Paul Tudor Jones
Reduced
$3.9M(-26.32%)Nov 14, 2024
Paul Tudor Jones
Increased
$4.1M(18.88%)Feb 14, 2025
Paul Tudor Jones
Sold
$0(-100.00%)May 15, 2025
Paul Tudor Jones
New
$94.9MAug 14, 2025
Paul Tudor Jones
Reduced
$92.8M(-21.66%)Dec 9, 2025
Paul Tudor Jones
Increased
$83.7M(54.99%)May 15, 2026
Paul Tudor Jones
Reduced
$87.5M(-9.58%)Aug 14, 2026
Ray Dalio
New
$85.9MNov 13, 2023
Ken Griffin
New
$582.8MAug 14, 2024
Izzy Englander
New
$293.8MMay 15, 2024
Paul Tudor Jones
New
$15MMay 15, 2024

Frequently asked questions

How many institutional investors hold ABBV?: 5 tracked institutional investors disclosed a position in ABBV (ABBVIE INC) in their most recent 13F filing.
Who is the largest institutional holder of ABBV?: Ken Griffin, Citadel Advisors, holds the largest disclosed position in ABBV, valued at $1.7B.
Did institutional ownership of ABBV increase or decrease?: Across recent 13F filings, tracked investors recorded 6 new positions, 15 increased, 18 reduced, and 2 fully exited ABBV.
What sector is ABBV in?: ABBVIE INC is classified in the Health Care GICS sector, Drug Manufacturers industry.
Where does this ABBV ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.